These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17614936)

  • 1. Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator.
    Campisi R; Marengo FD
    Cardiovasc Drug Rev; 2007; 25(2):132-45. PubMed ID: 17614936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tibolone: a unique version of hormone replacement therapy.
    Swegle JM; Kelly MW
    Ann Pharmacother; 2004 May; 38(5):874-81. PubMed ID: 15026563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-selectivity: the mechanism of action of tibolone.
    Kloosterboer HJ
    Maturitas; 2004 Aug; 48 Suppl 1():S30-40. PubMed ID: 15337246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
    Reginster JY
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
    Bots ML; Evans GW; Riley W; McBride KH; Paskett ED; Helmond FA; Grobbee DE;
    Eur Heart J; 2006 Mar; 27(6):746-55. PubMed ID: 16415304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tibolone on the breast of postmenopausal women.
    Wang PH; Cheng MH; Chao HT; Chao KC
    Taiwan J Obstet Gynecol; 2007 Jun; 46(2):121-6. PubMed ID: 17638619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tibolone: the way to beat many a postmenopausal ailments.
    Lazovic G; Radivojevic U; Marinkovic J
    Expert Opin Pharmacother; 2008 Apr; 9(6):1039-47. PubMed ID: 18377345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
    Diaby V; Perreault S; Lachaine J
    Maturitas; 2007 Oct; 58(2):138-49. PubMed ID: 17870259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal HRT and tibolone in relation to muscle strength and body composition.
    Jacobsen DE; Samson MM; Kezic S; Verhaar HJ
    Maturitas; 2007 Sep; 58(1):7-18. PubMed ID: 17576043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The need for tissue selective menopausal agents.
    Eden J
    Gynecol Endocrinol; 2005 Jul; 21 Suppl 1():22-7. PubMed ID: 16112952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group.
    Kenemans P; Speroff L;
    Maturitas; 2005 May; 51(1):21-8. PubMed ID: 15883105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tibolone on blood flow resistance and intima-media thickness of the carotid arteries: effect of time since menopause.
    Somunkiran A; Yazici B; Demirci F; Erdogmus B; Ozdemir I
    Climacteric; 2006 Feb; 9(1):59-65. PubMed ID: 16428126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
    Mirkin S; Archer DF
    Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy in women with past history of endometriosis.
    Soliman NF; Hillard TC
    Climacteric; 2006 Oct; 9(5):325-35. PubMed ID: 17000581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tibolone and its effects on bone: a review.
    Berning B; Bennink HJ; Fauser BC
    Climacteric; 2001 Jun; 4(2):120-36. PubMed ID: 11428176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tibolone on endogenous nitric oxide (nitrite/nitrate levels) in postmenopausal women.
    Akgül C; Canbaz M; Vural P
    Int J Fertil Womens Med; 2002; 47(1):13-7. PubMed ID: 11900269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives].
    Simoncini T; Mannella P; Genazzani AR
    Recenti Prog Med; 2003 Feb; 94(2):51-6. PubMed ID: 12908369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and tibolone metabolite levels in blood and breast tissue of postmenopausal women recently diagnosed with early-stage breast cancer and treated with tibolone or placebo for 14 days.
    Kloosterboer HJ; Löfgren L; von Schoulz E; von Schoultz B; Verheul HA
    Reprod Sci; 2007 Feb; 14(2):151-9. PubMed ID: 17636226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of menopause and tibolone on antioxidants in postmenopausal women.
    Vural P; Akgül C; Canbaz M
    Ann Clin Biochem; 2005 May; 42(Pt 3):220-3. PubMed ID: 15949158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.